BioCentury
ARTICLE | Clinical News

Elan, Wyeth-Ayerst regulatory update

January 15, 1996 8:00 AM UTC

Naprelan (naproxen sodium), a once-a-day formulation of naproxen, received FDA approval to treat arthritis. Naprelan tablets incorporate ELN’s intestinal protective drug absorption system, a matrix o...